This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69253630
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel artigo científico (publicado na 1989) artikull shkencor i botuar më 01 janar 1989 artículu científicu espublizáu en 1989 im Jahr 1989 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в січні 1989 գիտական հոդված հրատարակված 1989 թվականի հունվարի 1-ին scientific article published on 01 January 1989
p:P577
wds:Q69253630-D185BA3E-8F73-4BA0-9C78-AD6EF9151A6E
wdt:P577
1989-01-01T00:00:00Z
p:P2888
wds:Q69253630-EF729045-2589-4978-ABE9-2368AB0A821A
wdt:P2888
n11:bf00935852
p:P2860
wds:Q69253630-3511EC92-726A-4CD9-9F51-C83E27066BB0 wds:Q69253630-46FB2751-360E-43AD-8810-F677A6BA79CB wds:Q69253630-8C659409-9C02-450E-8DE4-5B8D80B157BB wds:Q69253630-ACEAB5B1-76DA-4B97-92E6-3468908045F4 wds:Q69253630-B72E8075-F375-4081-B6A6-6967195A3244 wds:Q69253630-C73CDF51-B444-4BDA-A76E-734896B249EF
wdt:P2860
wd:Q70324913 wd:Q67235319 wd:Q40258390 wd:Q42513262 wd:Q46021415 wd:Q46233171
p:P2093
wds:Q69253630-4E334919-23CD-41F6-BBEC-E43F435B68BA
wdt:P2093
J F Kerin
rdfs:label
The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles The advantages of a gonadotropin releasing hormone agonist
skos:prefLabel
The advantages of a gonadotropin releasing hormone agonist The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles
schema:name
The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles The advantages of a gonadotropin releasing hormone agonist The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles
p:P1476
wds:Q69253630-C6FF9FA8-1CEF-4862-AA9E-44C3597F2E29
wdt:P1476
The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles
p:P304
wds:Q69253630-4CF24305-1527-4F2B-96E0-43922F5D2FEA
wdt:P304
S45-52
p:P31
wds:Q69253630-C877B406-F60F-4949-AE58-73D94C2619DE
wdt:P31
wd:Q13442814
p:P921
wds:Q69253630-08CB85E1-7E48-4346-9D3D-79B5627BED50
wdt:P921
wd:Q907160
p:P698
wds:Q69253630-2480B042-FE1D-4915-A0DF-E7C895137FD7
wdtn:P698
n13:2511810
wdt:P698
2511810
p:P1433
wds:Q69253630-2D8A95DD-4BE1-462D-9377-5BFE889E4830
wdt:P1433
wd:Q15764214
p:P478
wds:Q69253630-BB99F984-3D99-4085-B96A-7F9D46BF8295
wdt:P478
246 Suppl
p:P356
wds:Q69253630-9699AA7F-125F-42E8-AE39-F1E5E4747B0A
wdtn:P356
n9:BF00935852
wdt:P356
10.1007/BF00935852
p:P6179
wds:Q69253630-E592CDB3-A5D1-4021-A5AB-87B3FAA6E3C1
wdt:P6179
1035594032